PIASy Mediates SUMO-2/3 Conjugation of Poly(ADP-ribose) Polymerase 1 (PARP1) on Mitotic Chromosomes

被引:42
|
作者
Ryu, Hyunju
Al-Ani, Gada
Deckert, Katelyn
Kirkpatrick, Donald [2 ]
Gygi, Steven P. [2 ]
Dasso, Mary [3 ]
Azuma, Yoshiaki [1 ]
机构
[1] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
[2] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[3] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20852 USA
基金
美国国家卫生研究院;
关键词
TOPOISOMERASE-II; SACCHAROMYCES-CEREVISIAE; PROTEIN SUMOYLATION; ACTIVE CENTROMERES; ENZYME; INTERACTS; CENPB; YEAST; BUB3;
D O I
10.1074/jbc.M109.074583
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PIASy is a small ubiquitin-related modifier (SUMO) ligase that modifies chromosomal proteins in mitotic Xenopus egg extracts and plays an essential role in mitotic chromosome segregation. We have isolated a novel SUMO-2/3-modified mitotic chromosomal protein and identified it as poly(ADP-ribose) polymerase 1 (PARP1). PARP1 was robustly conjugated to SUMO-2/ 3 on mitotic chromosomes but not on interphase chromatin. PIASy promotes SUMOylation of PARP1 both in egg extracts and in vitro reconstituted SUMOylation assays. Through tandem mass spectrometry analysis of mitotically SUMOylated PARP1, we identified a residue within the BRCA1 C-terminal domain of PARP1 (lysine 482) as its primary SUMOylation site. Mutation of this residue significantly reduced PARP1 SUMOylation in egg extracts and enhanced the accumulation of species derived from modification of secondary lysine residues in assays using purified components. SUMOylation of PARP1 did not alter in vitro PARP1 enzyme activity, poly-ADP-ribosylation (PARylation), nor did inhibition of SUMOylation of PARP1 alter the accumulation of PARP1 on mitotic chromosomes, suggesting that SUMOylation regulates neither the intrinsic activity of PARP1 nor its localization. However, loss of SUMOylation increased PARP1-dependent PARylation on isolated chromosomes, indicating SUMOylation controls the capacity of PARP1 to modify other chromatin-associated proteins.
引用
收藏
页码:14415 / 14423
页数:9
相关论文
共 50 条
  • [21] Hyperactivation of Poly (ADP-ribose) Polymerase 1 (PARP1) Triggers Global Metabolic Alterations in a Cellular Model of Glioblastoma
    Wilk, A. M.
    Johnston, B.
    Fouquerel, E.
    Cooper, S. J.
    Sobol, R. W.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2015, 56 : S61 - S61
  • [22] Transcriptional Reprogramming and Resistance to Colonic Mucosal Injury in Poly(ADP-ribose) Polymerase 1 (PARP1)-deficient Mice
    Larmonier, Claire B.
    Shehab, Kareem W.
    Laubitz, Daniel
    Jamwal, Deepa R.
    Ghishan, Fayez K.
    Kiela, Pawel R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (17) : 8918 - 8930
  • [23] Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib
    Gilabert, Marine
    Launay, Simon
    Ginestier, Christophe
    Bertucci, Francois
    Audebert, Stephane
    Pophillat, Mathieu
    Toiron, Yves
    Baudelet, Emilie
    Finetti, Pascal
    Noguchi, Tetsuro
    Sobol, Hagay
    Birnbaum, Daniel
    Borg, Jean-Paul
    Charafe-Jauffret, Emmanuelle
    Goncalves, Anthony
    PLOS ONE, 2014, 9 (08):
  • [24] Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update
    Jain, Priyancy G.
    Patel, Bhumika D.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 165 : 198 - 215
  • [25] Role of Poly(ADP-ribose) Polymerase 1 (PARP1) in the Modulation of Neutrophil Function: Relevance in Inflammatory Bowel Diseases
    Larmonier, Claire B.
    Shehab, Kareem W.
    McFadden, Rita-Marie T.
    Kiela, Pawel R.
    Ghishan, Fayez K.
    GASTROENTEROLOGY, 2015, 148 (04) : S326 - S327
  • [26] The 3′-5′ Exonuclease, TREX1, Interacts with Poly(ADP-ribose) Polymerase-1 (PARP1) in Response to DNA Damage
    Miyazaki, Takuya
    Kim, Yong-Soo
    Yoon, Jeong-Heon
    Wang, Hongsheng
    Morse, Herbert C., III
    BLOOD, 2012, 120 (21)
  • [27] Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage
    Moroni, Flavio
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (01) : 96 - 103
  • [28] Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast
    Perkins, E
    Sun, DX
    Nguyen, A
    Tulac, S
    Francesco, M
    Tavana, H
    Nguyen, H
    Tugendreich, S
    Barthmaier, P
    Couto, J
    Yeh, E
    Thode, S
    Jarnagin, K
    Jain, A
    Morgans, D
    Melese, T
    CANCER RESEARCH, 2001, 61 (10) : 4175 - 4183
  • [29] Therapeutic Potentials of Poly (ADP-Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting
    Wang, Yan
    Pleasure, David
    Deng, Wenbin
    Guo, Fuzheng
    ADVANCED SCIENCE, 2022, 9 (05)
  • [30] Poly(ADP-ribose) Polymerase 1 (PARP1) restrains MyoD-dependent gene expression during muscle differentiation
    Francesca Matteini
    Oriella Andresini
    Stefano Petrai
    Cecilia Battistelli
    Marianna Nicoletta Rossi
    Rossella Maione
    Scientific Reports, 10